Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer

NCT00878709 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2840

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: neratinib
OTHER: placebo

Sponsor

Puma Biotechnology, Inc.